These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15903058)

  • 1. [Depression--an important obstruction to the treatment of diabetes].
    Kulzer B
    MMW Fortschr Med; 2005 Apr; 147(17):37-40. PubMed ID: 15903058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome.
    Simson U; Nawarotzky U; Friese G; Porck W; Schottenfeld-Naor Y; Hahn S; Scherbaum WA; Kruse J
    Diabet Med; 2008 Feb; 25(2):206-12. PubMed ID: 18290863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus: how important is it to measure the quality of life?].
    Kulzer B
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S259-63. PubMed ID: 17139583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium.
    Pouwer F; Kupper N; Adriaanse MC
    Discov Med; 2010 Feb; 9(45):112-8. PubMed ID: 20193636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial.
    Stiefel F; Zdrojewski C; Bel Hadj F; Boffa D; Dorogi Y; So A; Ruiz J; de Jonge P
    Psychother Psychosom; 2008; 77(4):247-56. PubMed ID: 18443391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial factors contributing to persistent depressive symptoms in type 2 diabetic patients: a Croatian survey from the European Depression in Diabetes Research Consortium.
    Pibernik-Okanovic M; Begic D; Peros K; Szabo S; Metelko Z;
    J Diabetes Complications; 2008; 22(4):246-53. PubMed ID: 18413168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes and depression].
    Regen F; Merkl A; Heuser I; Dettling M; Anghelescu I
    Dtsch Med Wochenschr; 2005 Apr; 130(17):1097-102. PubMed ID: 15841425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment.
    Wagner J; Tsimikas J; Abbott G; de Groot M; Heapy A
    Diabetes Res Clin Pract; 2007 Jan; 75(1):119-22. PubMed ID: 16782225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of depression on quality of life of patients with type II diabetes mellitus.
    Eren I; Erdi O; Sahin M
    Depress Anxiety; 2008; 25(2):98-106. PubMed ID: 17311266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in Croatian Type 2 diabetic patients: prevalence and risk factors. A Croatian survey from the European Depression in Diabetes (EDID) Research Consortium.
    Pibernik-Okanovic M; Peros K; Szabo S; Begic D; Metelko Z
    Diabet Med; 2005 Jul; 22(7):942-5. PubMed ID: 15975112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study.
    Pawaskar MD; Anderson RT; Balkrishnan R
    Health Qual Life Outcomes; 2007 Aug; 5():50. PubMed ID: 17683531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms, not completing a depression screening questionnaire, and risk of poor compliance with regular primary care visits in patients with type 2 diabetes: the Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) study group.
    Hayashino Y; Suzuki H; Yamazaki K; Izumi K; Noda M; Kobayashi M
    Exp Clin Endocrinol Diabetes; 2011 May; 119(5):276-80. PubMed ID: 21031344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics.
    Fisher L; Skaff MM; Mullan JT; Arean P; Mohr D; Masharani U; Glasgow R; Laurencin G
    Diabetes Care; 2007 Mar; 30(3):542-8. PubMed ID: 17327318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes.
    Chyun DA; Melkus GD; Katten DM; Price WJ; Davey JA; Grey N; Heller G; Wackers FJ
    Biol Res Nurs; 2006 Apr; 7(4):279-88. PubMed ID: 16581898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive symptoms and risk factors in Chinese persons with type 2 diabetes.
    Xu L; Ren J; Cheng M; Tang K; Dong M; Hou X; Sun L; Chen L
    Arch Med Res; 2004; 35(4):301-7. PubMed ID: 15325504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychopathologic peculiarities in patients with diabetes mellitus and non-proliferative retinopathy].
    Korkeliia MT; Tsupkiridze LR; Kurashvili RB; Tsibadze AD; Kurashvili GR
    Georgian Med News; 2009 Jan; (166):54-7. PubMed ID: 19202220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and history of recurrent depression in postmenopausal women with Type 2 diabetes: a case-control study.
    Wagner J; Tennen H; Mansoor G; Abbott G
    J Diabetes Complications; 2009; 23(1):18-24. PubMed ID: 18413177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.